Ophthotech Corporation (NASDAQ:OPHT) will be issuing its quarterly earnings data before the market opens on Monday, November 6th. Analysts expect the company to announce earnings of ($0.84) per share for the quarter.

Ophthotech Corporation (OPHT) opened at 2.31 on Monday. Ophthotech Corporation has a 12-month low of $2.24 and a 12-month high of $40.34. The stock has a 50 day moving average price of $2.58 and a 200 day moving average price of $2.66. The stock’s market cap is $83.03 million.

A number of research analysts recently commented on OPHT shares. ValuEngine raised shares of Ophthotech Corporation from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Stifel Nicolaus reaffirmed a “hold” rating and issued a $4.00 price target on shares of Ophthotech Corporation in a report on Thursday, September 21st. Twelve investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $47.33.

TRADEMARK VIOLATION WARNING: “Ophthotech Corporation (OPHT) to Release Quarterly Earnings on Monday” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/10/30/ophthotech-corporation-opht-to-release-quarterly-earnings-on-monday.html.

About Ophthotech Corporation

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness.

Earnings History for Ophthotech Corporation (NASDAQ:OPHT)

Receive News & Ratings for Ophthotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ophthotech Corporation and related companies with MarketBeat.com's FREE daily email newsletter.